Identifying and moving levers of acceptance and uptake of recommended quality-assured paediatric ACTs for non-complicated malaria

19 Nov 2012

An MMV commissioned study to assess critical barriers to the acceptance and uptake of quality antimalarial medicines for children.

MMV commissioned this independent study by consultant Dr. Florence Camus-Bablon, focused on assessing critical barriers to the acceptance and uptake of quality antimalarial medicines for children. The study focuses on six francophone countries in Central and West Africa, and draws on a WHO-endorsed framework for evaluating barriers to access to essential medicines. It suggests interventions that could enhance acceptance and uptake of WHO-recommended medicines for children. The findings and recommendations expressed in this study are those of the author, and do not necessarily reflect the views of MMV.